Using Genetic Variation to Explore the Causal Effect of Maternal Pregnancy Adiposity on Future Offspring Adiposity: A Mendelian Randomisation Study
Year: 2017
Type: article
Study design: Observational Study
Abstract: BACKGROUND: It has been suggested that greater maternal adiposity during pregnancy affects lifelong risk of offspring fatness via intrauterine mechanisms. Our aim was to use Mendelian randomisation (MR) to investigate the causal effect of intrauterine exposure to greater maternal body mass index (BMI) on offspring BMI and fat mass from childhood to early adulthood. METHODS AND FINDINGS: We used maternal genetic variants as instrumental variables (IVs) to test the causal effect of maternal BMI in pregnancy on offspring fatness (BMI and dual-energy X-ray absorptiometry [DXA] determined fat mass index [FMI]) in a MR approach. This was investigated, with repeat measurements, from ages 7 to 18 in the Avon Longitudinal Study of Parents and Children (ALSPAC; n = 2,521 to 3,720 for different ages). We then sought to replicate findings with results for BMI at age 6 in Generation R (n = 2,337 for replication sample; n = 6,057 for total pooled sample). In confounder-adjusted multivariable regression in ALSPAC, a 1 standard deviation (SD, equivalent of 3.7 kg/m2) increase in maternal BMI was associated with a 0.25 SD (95% CI 0.21-0.29) increase in offspring BMI at age 7, with similar results at later ages and when FMI was used as the outcome. A weighted genetic risk score was generated from 32 genetic variants robustly associated with BMI (minimum F-statistic = 45 in ALSPAC). The MR results using this genetic risk score as an IV in ALSPAC were close to the null at all ages (e.g., 0.04 SD (95% CI -0.21-0.30) at age 7 and 0.03 SD (95% CI -0.26-0.32) at age 18 per SD increase in maternal BMI), which was similar when a 97 variant generic risk score was used in ALSPAC. When findings from age 7 in ALSPAC were meta-analysed with those from age 6 in Generation R, the pooled confounder-adjusted multivariable regression association was 0.22 SD (95% CI 0.19-0.25) per SD increase in maternal BMI and the pooled MR effect (pooling the 97 variant score results from ALSPAC with the 32 variant score results from Generation R) was 0.05 SD (95%CI -0.11-0.21) per SD increase in maternal BMI (p-value for difference between the two results = 0.05). A number of sensitivity analyses exploring violation of the MR results supported our main findings. However, power was limited for some of the sensitivity tests and further studies with relevant data on maternal, offspring, and paternal genotype are required to obtain more precise (and unbiased) causal estimates. CONCLUSIONS: Our findings provide little evidence to support a strong causal intrauterine effect of incrementally greater maternal BMI resulting in greater offspring adiposity.
Source: PLoS Medicine
Authors: Rebecca C. Richmond(Conceptualization, Formal analysis, Methodology, Validation, Visualization, Writing – original draft), Nicholas J. Timpson(Conceptualization, Funding acquisition, Writing – review & editing), Janine F. Felix(Funding acquisition, Methodology, Validation, Writing – review & editing), Tom Palmer(Formal analysis, Methodology, Software, Writing – review & editing), Romy Gaillard(Methodology, Validation, Writing – review & editing), George McMahon(Formal analysis, Methodology, Software, Writing – review & editing), George Davey Smith(Conceptualization, Funding acquisition, Writing – review & editing), Vincent W. Jaddoe(Conceptualization, Funding acquisition, Validation, Writing – review & editing), Debbie A. Lawlor(Conceptualization, Funding acquisition, Supervision, Writing – original draft)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,525
Funders: Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, European Commission, University of Bristol, ZonMw, Erasmus Universiteit Rotterdam, Erasmus Medisch Centrum, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, Horizon 2020 Framework Programme, Medical Research Council, European Research Council, National Institute of Diabetes and Digestive and Kidney Diseases, H2020 European Research Council
Awards: G1192034430, G149876332, G1516964218, G1605161196, G1795554050, NIHR Senior Investigator Award, G1938092250, G1987169411, G2123734861, G2164340656, G2292282800, Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active aging, G3344456887, Early-life stressors and LifeCycle health, G434337789, G4418645022, ALSPAC The Avon Longitudinal Study for Parents and Children: An international resource for population genomic and lifecourse epidemiology. Core programme support 2014-2019., The Avon Longitudinal Study of Parents and Children: An international resource for population
genomics and lifecourse epidemiology. Core Programme Support 2011-2015 and Core programme support 2014-2019, G4858608219, G490277885, G5001017760, G6119919417, G6251221280, G6383967859, G6423108142, G6520203987, G6563565772, G6682065591, Effects of maternal gestational adiposity on fetal development and perinatal, postnatal and next generation health., G7095874527, Metabolomic and Epigenomic Mechanisms in Developmental Overnutrition., G7758688404, What lies behind the causal impact of body mass index (BMI) level and change on human health? Added value from complementary study design and deep metabolomic phenotyping., G8413721682
OpenAlex ID: W2580021247
